Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has been assigned an average recommendation of “Buy” from the fifteen research firms that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $24.79.

Several analysts have issued reports on PRVA shares. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Truist Financial increased their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Barclays boosted their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Robert W. Baird raised their price target on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Finally, KeyCorp initiated coverage on Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price target for the company.

Privia Health Group Trading Up 0.3 %

Shares of Privia Health Group stock opened at $20.96 on Friday. The company’s 50-day moving average price is $19.96 and its 200-day moving average price is $19.01. The company has a market cap of $2.52 billion, a price-to-earnings ratio of 209.62, a PEG ratio of 5.49 and a beta of 0.83. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $24.30.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors have recently made changes to their positions in PRVA. Sequoia Financial Advisors LLC raised its position in Privia Health Group by 2.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock worth $478,000 after purchasing an additional 583 shares during the period. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Privia Health Group by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock valued at $134,000 after acquiring an additional 605 shares during the last quarter. Arizona State Retirement System boosted its holdings in Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock valued at $462,000 after acquiring an additional 617 shares during the period. Signaturefd LLC boosted its holdings in Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after acquiring an additional 626 shares during the period. Finally, Parkside Financial Bank & Trust grew its position in Privia Health Group by 9.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock worth $151,000 after acquiring an additional 771 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.